Abstract | BACKGROUND: OBJECTIVE: The objective of this study was to quantify changes in hormones that regulate energy homeostasis and appetitive sensations before and after LAGB (n = 18) and RYGB (n = 38) in order to better understand the mechanisms underlying the greater weight loss after RYGB. METHODS: A standardized test meal was administered prior to surgery, at 6 months, and annually thereafter to year 2 after LAGB and year 4 after RYGB. Blood samples were obtained in the fasted state and 30, 60, 90, and 120 min post-meal. RESULTS: Progressive increases in fasting PYY were observed after RYGB together with increases in postprandial area under the curve (AUC) levels that were unchanged after LAGB. GLP-1 AUC increased only after RYGB. There was a weight loss-related increase in fasting ghrelin levels after LAGB that was unchanged 1 year after RYGB despite greater percentage weight loss; ghrelin subsequently increased at years 2-4 post-RYGB. HOMA-IR decreased after both procedures but correlated with weight loss only after LAGB, whereas leptin correlated with weight loss in both groups. Sweet cravings decreased after RYGB. CONCLUSION: A number of weight loss-independent changes in the gut hormonal milieu likely act in concert to promote a decrease in insulin resistance and greater weight loss efficacy after RYGB. A progressive change in hormone levels over time may reflect gut enteroplasticity after RYGB. A decrease in sweet cravings specific to RYGB may further promote superior weight loss outcomes.
|
Authors | Alina I Tsouristakis, Gerardo Febres, Donald J McMahon, Beverly Tchang, Irene M Conwell, Amanda J Tsang, Leaque Ahmed, Marc Bessler, Judith Korner |
Journal | Obesity surgery
(Obes Surg)
Vol. 29
Issue 11
Pg. 3698-3705
(11 2019)
ISSN: 1708-0428 [Electronic] United States |
PMID | 31376135
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Ghrelin
- Insulin
- Glucagon-Like Peptide 1
|
Topics |
- Appetite
(physiology)
- Bariatric Surgery
(statistics & numerical data)
- Craving
(physiology)
- Ghrelin
(blood)
- Glucagon-Like Peptide 1
(blood)
- Humans
- Insulin
(blood)
- Obesity
(metabolism, surgery)
- Weight Loss
(physiology)
|